Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Credit agrmnt [a]
CC transcript
|
|
CORE LABORATORIES N V (CLB)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/12/2023 |
SC 13G/A
| ALGER ASSOCIATES INC reports a 0% stake in Core Laboratories N.V. |
| 05/02/2023 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 04/27/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 04/26/2023 |
8-K
| Quarterly results |
| 02/28/2023 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition: |
| 02/14/2023 |
SC 13G/A
| ALGER ASSOCIATES INC reports a 8.3% stake in Core Laboratories N.V. |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2023 |
SC 13G/A
| EARNEST PARTNERS LLC reports a 7.7% stake in CORE LABORATORIES N.V. |
| 02/03/2023 |
8-K
| Quarterly results |
| 02/01/2023 |
8-K
| Quarterly results |
| 01/26/2023 |
SC 13G/A
| BlackRock Inc. reports a 12.6% stake in CORE LABORATORIES N V |
| 01/20/2023 |
SC 13G/A
| BlackRock Inc. reports a 12.6% stake in CORE LABORATORIES N V |
| 01/17/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 01/17/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 01/17/2023 |
8-K
| Quarterly results |
| 11/04/2022 |
8-K
| Quarterly results |
| 10/27/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 10/26/2022 |
8-K
| Quarterly results |
| 07/28/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 07/27/2022 |
8-K
| Quarterly results|
Docs:
|
"CORE LABORATORIES N.V. & SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Three Months Ended % Variance June 30, 2022 June 30, 2021 vs. Q1-22 vs. Q2-21 REVENUE $120,898 $115,300 $118,745 4.9% 1.8% OPERATING EXPENSES: Costs of services and sales 97,957 96,952 93,841 1.0% 4.4% General and administrative expense 6,847 12,545 9,670 % % Depreciation and amortization 4,360 4,557 4,751 % % Other expense, net 82 1,637 % NM Total operating expenses 109,246 115,691 105,945 % 3.1% OPERATING INCOME 11,652 12,800 NM % Interest expense 2,707 2,644 2,530 2.4% 7.0% Income from continuing operations before income tax expense 8,945 10,270 NM % Income tax expense 1,789 2,053 NM % Income from continuing operations 7,156 8,217 NM % Net income 7,156 8,217 NM % Net income attributable to non-control..." |
|
| 07/26/2022 |
8-K
| Quarterly results |
| 06/29/2022 |
11-K
| Form 11-K - Annual report of employee stock purchase, savings and similar plans: |
| 06/09/2022 |
UPLOAD
| Form UPLOAD - SEC-generated letter: |
| 06/09/2022 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 06/09/2022 |
8-K
| Quarterly results |
| 06/08/2022 |
8-K
| Quarterly results |
| 06/07/2022 |
CORRESP
| Form CORRESP - Correspondence: |
| 06/02/2022 |
CORRESP
| Form CORRESP - Correspondence: |
| 05/24/2022 |
SD
| Form SD - Specialized disclosure report: |
| 05/19/2022 |
8-K
| Quarterly results |
| 05/18/2022 |
UPLOAD
| Form UPLOAD - SEC-generated letter: |
| 04/28/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 04/27/2022 |
8-K
| Quarterly results|
Docs:
|
"CORE LABORATORIES N.V. & SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Three Months Ended % Variance vs. Q4-21 vs. Q1-21 REVENUE $ 115,300 $ 125,139 $ 108,383 % 6.4% OPERATING EXPENSES: Costs of services and sales 96,952 96,987 84,150 —% 15.2% General and administrative expense 12,545 10,927 8,461 14.8% 48.3% Depreciation and amortization 4,557 4,398 4,871 3.6% % Other expense, net 1,637 NM NM Total operating expenses 115,691 110,939 96,761 4.3% 19.6% OPERATING INCOME 14,200 11,622 NM NM Interest expense 2,644 2,590 1,363 2.1% 94.0% Income from continuing operations before income tax expense 11,610 10,259 NM NM Income tax expense 8,823 2,052 NM NM Income from continuing operations 2,787 8,207 NM NM Net income 2,787 8,207 NM NM Net income attributable to non-controlling ..." |
|
| 03/24/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
|
|
|